Mondrian Investment Partners LTD - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 392 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
Mondrian Investment Partners LTD ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$61,225,725
-4.5%
4,081,7150.0%1.26%
-1.6%
Q2 2023$64,123,743
-4.7%
4,081,7150.0%1.28%
-13.6%
Q1 2023$67,266,663
+96156.1%
4,081,715
-6.5%
1.48%
-4.0%
Q4 2022$69,883
-99.9%
4,367,715
-8.1%
1.55%
+14.3%
Q3 2022$61,772,000
-7.1%
4,751,7150.0%1.35%
-2.7%
Q2 2022$66,524,000
+10.0%
4,751,715
+10.0%
1.39%
+11.8%
Q1 2022$60,476,000
+6.4%
4,319,715
+6.4%
1.24%
+10.6%
Q4 2021$56,822,000
-4.1%
4,058,715
+9.6%
1.12%
-6.1%
Q3 2021$59,254,000
-5.9%
3,703,4040.0%1.20%
-0.6%
Q2 2021$62,958,000
+5.5%
3,703,404
+5.5%
1.20%
-5.8%
Q1 2021$59,677,000
+1.2%
3,510,404
+7.2%
1.28%
-12.3%
Q4 2020$58,944,000
+28.9%
3,274,660
+7.4%
1.46%
-8.1%
Q3 2020$45,742,000
-16.1%
3,049,474
+0.7%
1.58%
-18.9%
Q2 2020$54,534,000
+6.0%
3,029,646
-11.7%
1.95%
+8.6%
Q1 2020$51,438,000
-29.3%
3,429,170
-5.8%
1.80%
-6.0%
Q4 2019$72,783,000
+17.6%
3,639,1700.0%1.91%
-4.1%
Q3 2019$61,866,000
+0.8%
3,639,170
+6.7%
2.00%
+1.8%
Q2 2019$61,383,000
+1.9%
3,410,170
+13.2%
1.96%
+3.0%
Q1 2019$60,257,000
+23.3%
3,012,870
+4.8%
1.90%
+6.0%
Q4 2018$48,856,0002,873,8701.79%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2019
NameSharesValueWeighting ↓
Adelphi Capital LLP 7,584,930$138,046,00026.79%
Glenview Capital Management 15,260,512$277,741,0006.37%
Paulson & Co. 11,295,846$205,584,0005.34%
GMT CAPITAL CORP 2,871,395$52,259,0003.72%
MANAGED ASSET PORTFOLIOS, LLC 966,643$17,593,0003.09%
TFG Asset Management GP Ltd 1,443,052$26,264,0001.76%
Mondrian Investment Partners LTD 3,274,660$58,944,0001.46%
Blackcrane Capital, LLC 35,236$641,0001.26%
Lumbard & Kellner, LLC 136,378$2,404,0000.95%
DAVIDSON INVESTMENT ADVISORS 509,800$9,278,0000.86%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders